| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Caroline Lamarche | Q64514998 |
| Jean-Sébastien Delisle | Q73833054 | ||
| Marie-Josée Hébert | Q40276349 | ||
| P2093 | author name string | Julie Orio | |
| Lee Anne Tibbles | |||
| Lynne Senécal | |||
| Suzon Collette | |||
| Édith Renoult | |||
| P2860 | cites work | Polyomaviruses and disease: is there more to know than viremia and viruria? | Q28081350 |
| New human papovavirus (B.K.) isolated from urine after renal transplantation | Q28236639 | ||
| Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors | Q28244625 | ||
| Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus | Q30301338 | ||
| Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study | Q30422449 | ||
| Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder | Q33267775 | ||
| An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States | Q33427765 | ||
| Urinary proinflammatory cytokine response in renal transplant recipients with polyomavirus BK viruria | Q33515560 | ||
| Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients | Q33606896 | ||
| Leflunomide inhibition of BK virus replication in renal tubular epithelial cells | Q33614540 | ||
| Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients | Q33634455 | ||
| Urinary-cell mRNA profile and acute cellular rejection in kidney allografts | Q34037420 | ||
| Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches | Q44419275 | ||
| Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy | Q44498475 | ||
| BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis | Q44571746 | ||
| HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients | Q45058863 | ||
| BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression | Q45103464 | ||
| Polyomavirus nephropathy in pediatric kidney transplant recipients | Q45171047 | ||
| Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction | Q45262232 | ||
| Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system | Q45267785 | ||
| BK Virus Infection After Kidney Transplantation: The Data Are Mounting for a Personalized Approach | Q45339039 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patients | Q45352216 | ||
| BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses | Q45362434 | ||
| BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy. | Q45364259 | ||
| Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study | Q45395619 | ||
| Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults | Q45399744 | ||
| Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia | Q45427404 | ||
| BK Polyoma Virus Allograft Nephropathy: Ultrastructural Features from Viral Cell Entry to Lysis | Q45710937 | ||
| Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine | Q45730363 | ||
| BK virus regulatory region rearrangements in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitis | Q45732749 | ||
| Identification of archetype and rearranged forms of BK virus in leukocytes from healthy individuals | Q45745122 | ||
| Human polyoma virus-associated interstitial nephritis in the allograft kidney | Q45751593 | ||
| BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions | Q45778896 | ||
| Renal failure due to BK virus infection in an immunodeficient child | Q45785284 | ||
| Human polyomavirus in pregnancy. A model for the study of defence mechanisms to virus reactivation | Q45797965 | ||
| The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils | Q45799462 | ||
| The effects of renal transplantation on circulating dendritic cells. | Q46419669 | ||
| Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy | Q46687452 | ||
| Dendritic cell deficiency in the blood of kidney transplant patients on long-term immunosuppression: results of a prospective matched-cohort study | Q46816114 | ||
| Reduced exposure to calcineurin inhibitors in renal transplantation | Q46840533 | ||
| BKV and SV40 infection of human kidney tubular epithelial cells in vitro | Q47354606 | ||
| Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. | Q47763052 | ||
| BK and JC viruses in patients with systemic lupus erythematosus: prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia | Q47959065 | ||
| Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals | Q48086009 | ||
| Evidence of human polyomavirus BK and JC infection in normal brain tissue | Q48416768 | ||
| Isolation of papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich syndrome | Q48512511 | ||
| Pathology of resolving polyomavirus-associated nephropathy. | Q51873284 | ||
| Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2. | Q54200595 | ||
| A human papovavirus (B.K.), biological properties and seroepidemiology. | Q54250082 | ||
| Dendritic cell deficiency associated with development of BK viremia and nephropathy in renal transplant recipients. | Q54446958 | ||
| Tubulo-Interstitial Nephritis Associated with Polyomavirus (BK Type) Infection | Q67287983 | ||
| Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants | Q70142893 | ||
| Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre | Q74016225 | ||
| Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent | Q74493975 | ||
| The induction of neoplasms with a substance released from mouse tumors by tissue culture | Q74512300 | ||
| Polyomavirus BK non-coding control region rearrangements in health and disease | Q80538891 | ||
| Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy | Q80798773 | ||
| Polyomavirus BK-specific immunity after kidney transplantation | Q80903029 | ||
| The effects of renal transplantation on peripheral blood dendritic cells | Q81175772 | ||
| Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients | Q81379957 | ||
| HLA susceptibility to BKV infection | Q82515115 | ||
| Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation | Q84357905 | ||
| Interobserver agreement for Polyomavirus nephropathy grading in renal allografts using the working proposal from the 10th Banff Conference on Allograft Pathology | Q84512637 | ||
| Prevalence in England of antibody to human polyomavirus (B.k.). | Q84953205 | ||
| Reactivation of polyoma virus in kidneys of persistently infected mice during pregnancy | Q34092581 | ||
| A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice | Q34232505 | ||
| Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. | Q34273968 | ||
| Agnoprotein of mammalian polyomaviruses | Q34283583 | ||
| Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers | Q34337472 | ||
| Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection | Q34437449 | ||
| Role of a nuclear localization signal on the minor capsid proteins VP2 and VP3 in BKPyV nuclear entry. | Q34451457 | ||
| Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy | Q34545686 | ||
| Oncogenic potentials of the human polyomavirus regulatory proteins | Q34625941 | ||
| Polyomavirus BK neutralizing activity in human immunoglobulin preparations | Q34786755 | ||
| Polyomavirus BK. | Q35548648 | ||
| Stimulation of BK virus DNA replication by NFI family transcription factors | Q35826187 | ||
| The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome | Q35870126 | ||
| The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations | Q35989434 | ||
| Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations | Q36136619 | ||
| BK virus: opportunity makes a pathogen | Q36188861 | ||
| Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement. | Q36297604 | ||
| A serological investigation of BK virus and JC virus infections in recipients of renal allografts | Q36342486 | ||
| High Prevalence of Antibodies to BK Virus, an SV40-related Papovavirus, in Residents of Maryland | Q36520893 | ||
| Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology | Q36537931 | ||
| Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients | Q36598800 | ||
| A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. | Q36632077 | ||
| Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration | Q36643498 | ||
| Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation | Q36965036 | ||
| Immune evasion of natural killer cells by viruses | Q37060710 | ||
| Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients | Q37086788 | ||
| BK virus antibody titers and intensity of infections after renal transplantation | Q37239525 | ||
| HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia | Q37349698 | ||
| The Polyomaviridae: Contributions of virus structure to our understanding of virus receptors and infectious entry | Q37373700 | ||
| Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial | Q37621540 | ||
| Noninvasive prognostication of polyomavirus BK virus-associated nephropathy | Q37631149 | ||
| BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results | Q37670279 | ||
| Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. | Q37678906 | ||
| Review on the relationship between human polyomaviruses-associated tumors and host immune system | Q38001435 | ||
| BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenetic model. | Q38073911 | ||
| Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation | Q38220648 | ||
| ERAD and how viruses exploit it. | Q38234935 | ||
| Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies | Q38276074 | ||
| Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial | Q38420919 | ||
| Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. | Q38454485 | ||
| BK Virus Nephropathy in Kidney Transplantation: An Approach Proposal and Update on Risk Factors, Diagnosis, and Treatment | Q38570451 | ||
| Inhibition of BK virus replication in human kidney cells by BK virus large tumor antigen-specific shRNA delivered by JC virus-like particles | Q39035911 | ||
| Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells | Q39499064 | ||
| An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination | Q39592344 | ||
| Anti-BK Virus Mechanisms of Sirolimus and Leflunomide Alone and in Combination: Toward a New Therapy for BK Virus Infection | Q39631502 | ||
| KDIGO clinical practice guideline for the care of kidney transplant recipients | Q39936865 | ||
| Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones. | Q40132770 | ||
| HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity | Q40351825 | ||
| Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. | Q40613236 | ||
| Risk Factors for BK Polyoma Virus Treatment and Association of Treatment With Kidney Transplant Failure: Insights From a Paired Kidney Analysis | Q40745543 | ||
| Intragraft Blood Dendritic Cell Antigen-1-Positive Myeloid Dendritic Cells Increase during BK Polyomavirus-Associated Nephropathy | Q40858336 | ||
| Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling | Q41000259 | ||
| The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. | Q41103097 | ||
| Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients | Q41432471 | ||
| Clinical Utility of Urinary Cytology to Detect BK Viral Nephropathy | Q41432805 | ||
| Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature | Q41477413 | ||
| Sp1 sites in the noncoding control region of BK polyomavirus are key regulators of bidirectional viral early and late gene expression | Q41544370 | ||
| Persistence of DNA Sequences of BK Virus and JC Virus in Normal Human Tissues and in Diseased Tissues | Q41555932 | ||
| The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD. | Q42200730 | ||
| BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication | Q42225033 | ||
| High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation | Q42230071 | ||
| Genomics of BK viremia in kidney transplant recipients | Q42250844 | ||
| BK polyomavirus in solid organ transplantation | Q42272314 | ||
| Treatment of BK viremia after renal transplantation: are fluoroquinolones a false dawn? | Q42420884 | ||
| Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease | Q42754947 | ||
| Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. | Q42790826 | ||
| Renal Failure Five Years After Lung Transplantation Due to Polyomavirus BK‐Associated Nephropathy | Q42907634 | ||
| BK virus large T and VP-1 expression in infected human renal allografts | Q43184361 | ||
| Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation | Q43225933 | ||
| Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs | Q43236446 | ||
| Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring | Q43536824 | ||
| Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis | Q43605141 | ||
| Donor and recipient BKV-specific IgG antibody and posttransplantation BKV infection: a prospective single-center study | Q43660039 | ||
| BK-VP3 as a new target of cellular immunity in BK virus infection | Q43702582 | ||
| Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy | Q43782396 | ||
| Limited efficacy of immunosuppressive drugs on CD8+ T cell-mediated and natural killer cell-mediated lysis of human renal tubular epithelial cells | Q43900811 | ||
| Sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids: focus on acute rejection, patient and graft survival | Q44019892 | ||
| Clinical course of polyoma virus nephropathy in 67 renal transplant patients | Q44077395 | ||
| Risk factors for BK virus infection in the era of therapeutic drug monitoring | Q44077791 | ||
| Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients | Q44104230 | ||
| Molecular evaluation of BK polyomavirus nephropathy | Q44313013 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| BK virus | Q582873 | ||
| kidney transplantation | Q740909 | ||
| tumor virus infections | Q69561737 | ||
| P304 | page(s) | 2276-2287 | |
| P577 | publication date | 2016-07-07 | |
| 2016-11-01 | |||
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches | |
| P478 | volume | 100 |
| Q92531711 | Acute Rejection in Kidney Transplantation and Early Beginning of Tacrolimus |
| Q47557746 | Aryl hydrocarbon receptor expression by macrophages and lymphocytes within infiltrates in BK polyomavirus associated nephropathy |
| Q37747582 | BK viruria and viremia in children with systemic lupus erythematosus |
| Q90734448 | Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts |
| Q59359682 | High-Dose Intravenous Immunoglobulin Treatment of Polyomavirus Nephropathy Developing After T Cell-Mediated Rejection Treatment: A Case Report |
| Q97535447 | Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature |
| Q92068281 | Non-invasive urinary sediment double-immunostaining predicts BK polyomavirus associated-nephropathy in kidney transplant recipients |
| Q99583669 | Pathological characteristics of BK polyomavirus-associated nephropathy with glomerular involvement |
| Q90176540 | The immunophenotyping of different stages of BK virus allograft nephropathy |
| Q64109430 | The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy |
| Q40039485 | Treatment of Theiler's virus-induced demyelinating disease with teriflunomide. |
| Q47602423 | Treatment of human polyomavirus-7-associated rash and pruritus with topical cidofovir in a lung transplant patient: Case report and literature review. |
| Q40115230 | Urothelial cell carcinoma after BK polyomavirus infection in kidney transplant recipients: A cohort study of veterans. |
Search more.